Introduction
Non-syndromic orofacial clefts (OFC) and tooth agenesis (TA) are two of the most common craniofacial birth defects [1, 2] . OFC affect 1 per 700 live births in the global population [1] . According to the Polish Registry of Congenital Malformations, the prevalence of orofacial clefts in Poland ranges from 1/500 to 1/1000 births [www.rejestrwad.pl] . OFC are divided into two main forms: non-syndromic cleft lip with or without cleft palate and cleft palate only [3] . The incidence of TA, excluding the lack of the third molars, varies from 1.6 to 9.6% depending on ethnic background [2] . TA can be classifi ed based on the number of missing teeth into hypodontia (the lack of one to fi ve teeth), oligodontia (the lack of 6 or more teeth) and anodontia (the complete absence of teeth). In this classifi cation, the third molars are not taken into account since their absence is highly prevalent [2] . The co-occurrence of OFC and TA is often reported [4, 5] . Patients with OFC have an increased risk of dental anomalies, including alteration in tooth number, size, shape, a timing of formation and eruption comparing to the general population [6] . It has been shown that dental anomalies appear primarily in the cleft area and their prevalence is higher in left-sided OFC [7] . Additionally, in patients with OFC the agenesis of teeth outside the cleft area have also been reported to be more frequent [8] . This observation may indicate that the same molecular mechanisms may be shared in the development of the teeth, palate, and lip [8] .
The etiology of non-syndromic OFC and TA is complex with genetic and environmental components [3, 9] . Additionally, the epigenetic modifi cations have been implicated in the pathogenesis of these structural malformations [10] . Genetic studies using a variety of research approaches, including linkage studies, candidate gene analyses, and genome-wide association studies, have identifi ed a number of genes and chromosomal regions underlying these craniofacial anomalies [9, 11] . However, nucleotide variants of identifi ed
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candidate genes and chromosomal loci can still explain only a fraction of the predicted heritability. It has been demonstrated that both OFC and TA have a number of common candidate genes, which nucleotide variants can influence their risk [4, 5] .
Across OFC' studies conducted in various populations, including the Polish population, the most consistent results were observed for nucleotide variants located in the IRF6 gene (OMIM *607199) and the chromosomal region 8q24.21 [12] [13] [14] . The IRF6 gene encodes a transcription factor, which is involved in the regulation of the keratinocyte proliferation-differentiation switch and formation of oral periderm [15] . It is worth noting that in a study conducted in the Latvian population, the IRF6 variant (rs642961) located in the promoter region was found to be more frequent in individuals presenting OFC associated with tooth agenesis when compared to healthy individuals [16] . Moreover, Vieira et al. have demonstrated that this functional variant, disrupting an AP-2α binding site in the IRF6 enhancer, is associated with the risk of isolated TA [12, 17, 18] . The 8q24.21 risk locus, identifi ed by the fi rst genome-wide association study conducted for OFC and further confi rmed by a number of post-GWAS replication studies, is a gene-poor region devoid of protein-coding genes [19, 20] . Studies using mice as model organisms have demonstrated that this chromosomal locus contains very distant cis-acting enhancers controlling the expression of the Myc gene during craniofacial development [21] . Mice homozygous for the deletion including this medionasal enhancer region show mild alterations in the face morphology and occasionally cleft lip and palate [21] . Within the 8q24.21 chromosomal region, which nowadays is considered as a key susceptibility locus for non-syndromic OFC, the top marker associated with the risk of this anomaly is rs987525 [19] . A signifi cant association between this intragenic variant and the co-occurrence of OFC and TA outside the cleft region was also observed [22] .
The major candidate genes for non-syndromic TA include WNT10A (OMIM *606268), MSX1 (OMIM *142983), PAX9 (OMIM *167416), AXIN2 (OMIM *604025), EDA (OMIM *300451) and EDAR (OMIM *604095). Van den Boogaard et al. [23] have demonstrated that the WNT10A mutations are present in more than 50% isolated TA cases. Pathogenic mutations within the coding region of WNT10A have also been identifi ed in 62% of tooth agenesis patients from the Polish population [24] . The WNT10A gene is a member of the Wnt family, which consists of genes encoding secreted signaling proteins involved in a number of developmental processes during embryogenesis [25] . Interestingly, the missense mutation of the WNT10A gene has been associated with the increased risk of non-syndromic OFC in the Chinese population [26] . Moreover, nucleotide variants in WNT3 (OMIM *165330), WNT3A (OMIM *606359), WNT5A (OMIM *164975), WNT9A (OMIM *602863), and WNT11 (OMIM *603699) have been found to be signifi cantly associated with non-syndromic orofacial clefts in various populations [27, 28] . Similarly, polymorphisms and mutations in the MSX1 gene are known factors increasing the risk of non-syndromic OFC [29] . In addition, MSX1 and two other major TA candidate genes, PAX9 and AXIN2, have been associated with the co-occurrence of cleft anomalies and TA [5] . The MSX1 and PAX9 genes encode transcription factors that play an essential role during embryogenesis [9] . It has been demonstrated that these genes are co-expressed during craniofacial development, and the genetic interactions between their protein products are involved in the regulation of the lip formation and tooth morphogenesis [30] . Msx1 and Pax9 defi cient mice lack all teeth, which development is arrested at the bud stage, and exhibit a number of craniofacial defects, including cleft palate [31, 32] . The AXIN2 gene encodes a protein which is a negative regulator of the Wnt-signalling pathway [33] .
Besides the genes described above, there are a number of other candidate genes and chromosomal loci underlying the co-occurrence of OFC and TA. The systemic review conducted by Phan et al. [5] revealed that they include among others the TGF pathway genes and the cancer predisposing gene CDH1 (OMIM *192090) .
In summary, OFC and TA are one of the most common craniofacial anomalies that share a number of common candidate genes. There is growing evidence suggesting that tooth agenesis should be considered as an extended phenotype for oral clefts [34] .
